Catalyst Wire Dossier Catalyst Wire Dossier

Tibulizumab

Tibulizumab · Zura Bio Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tibulizumab, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) [Phase 2]

See pricing